Short answer · Medically reviewed summary · Last updated: 2026-04-07
Apert Syndrome is a genetic condition caused by a mutation in the FGFR2 gene, but it is rarely inherited from parents, as the vast majority of cases occur as a de novo (spontaneous) mutation. Understanding Inheritance and De Novo Mutations While Apert Syndrome is a genetic disorder, it is typically not hereditary in the sense of being passed down through generations. The condition follows an autosomal dominant inheritance pattern, meaning only one copy of the altered gene is necessary to cause the syndrome.
Is Apert Syndrome hereditary?
Is Apert Syndrome hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Apert Syndrome is a genetic condition caused by a mutation in the FGFR2 gene, but it is rarely inherited from parents, as the vast majority of cases occur as a de novo (spontaneous) mutation.
Understanding Inheritance and De Novo Mutations
While Apert Syndrome is a genetic disorder, it is typically not hereditary in the sense of being passed down through generations. The condition follows an autosomal dominant inheritance pattern, meaning only one copy of the altered gene is necessary to cause the syndrome. However, because the physical manifestations of Apert Syndrome often affect fertility and social development, most individuals with the condition do not have children. Consequently, most cases arise from a new, spontaneous mutation in the egg or sperm at the time of conception. It is important to know that this is a random biological event and is not caused by anything the parents did or did not do during pregnancy.
Risk and Genetic Counseling
For an individual who has Apert Syndrome, the risk of passing the condition to a child is 50% for each pregnancy. For parents who have one child with the syndrome and do not have the condition themselves, the risk of having another child with Apert Syndrome is extremely low, generally less than 1%, due to the possibility of germline mosaicism. Genetic counseling is highly recommended for families to discuss these probabilities, understand the specific FGFR2 mutation involved, and explore reproductive options.
Genetic Testing and Diagnosis
Genetic testing is the gold standard for confirming a diagnosis of Apert Syndrome. Testing involves a blood sample to identify pathogenic variants in the FGFR2 gene. If a specific mutation has been identified in a family, prenatal diagnosis via chorionic villus sampling (CVS) or amniocentesis can be performed in future pregnancies. We encourage families to connect with a clinical geneticist to review individual test results and discuss family planning in a supportive environment.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet (Portal for rare diseases and orphan drugs)
- Online Mendelian Inheritance in Man (OMIM)
